{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:37:29Z","timestamp":1779925049185,"version":"3.53.1"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T00:00:00Z","timestamp":1399593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0097067","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T17:40:28Z","timestamp":1399657228000},"page":"e97067","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["High-Level Cross-Resistance to Didanosine Observed in South African Children Failing an Abacavir- or Stavudine-Based 1st-Line Regimen"],"prefix":"10.1371","volume":"9","author":[{"given":"Kim","family":"Steegen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Ketseoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Bronze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Papathanasopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,5,9]]},"reference":[{"key":"ref1","unstructured":"UNAIDS (2012) Fact Sheet South Africa. UNAIDS."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4102\/sajhivmed.v13i1.156","article-title":"Access to Antiretroviral Treatment in South Africa, 2004\u20132011","volume":"13","author":"LF Johnson","year":"2012","journal-title":"S Afr J HIV Med"},{"key":"ref3","unstructured":"Dlamini NR (2012) Circular Minute 2 of 2012: Initiation of antiretroviral treatment (ART) to all HIV positive children aged 5 years and under regardless of CD4 counts and\/or WHO clinical staging. In: NDoH, editor. South Africa."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"Early antiretroviral therapy and mortality among HIV-infected infants","volume":"359","author":"A Violari","year":"2008","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/INF.0b013e3181ed2af3","article-title":"Long-term outcome of children receiving antiretroviral treatment in rural South Africa: substantial virologic failure on first-line treatment","volume":"30","author":"RE Barth","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/INF.0b013e3182829092","article-title":"Resistance in pediatric patients experiencing virologic failure with first-line and second-line antiretroviral therapy","volume":"32","author":"C Orrell","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1089\/aid.2010.0205","article-title":"Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than two years of age initiating protease inhibitor-based therapy in South Africa","volume":"27","author":"BS Taylor","year":"2011","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/INF.0b013e3181af829d","article-title":"Protease inhibitor resistance in South African children with virologic failure","volume":"28","author":"GU van Zyl","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/INF.0b013e3181af5a00","article-title":"Emergence of drug resistance in HIV-1 subtype C infected children failing the South African national antiretroviral roll-out program","volume":"28","author":"CL Wallis","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"ref10","unstructured":"(2010) South African Guidelines for the Management of HIV in Children. In: NDoH, editor."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/molbev\/msm092","article-title":"MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0","volume":"24","author":"K Tamura","year":"2007","journal-title":"Mol Biol Evol"},{"key":"ref12","unstructured":"Bronze M, Moodley K, Steegen K, Papathanasopolous MA, Carmona S, <etal>et al<\/etal>.. (2012) Development and validation of a one-step genotyping protocol encompassing HIV-1 protease and reverse transcriptase for patient antiretroviral drug resistance monitoring. 1st International Conference African Society for Laboratory Medicine, Cape Town, South Africa."},{"key":"ref13","unstructured":"Lukhwareni A, Bronze M, Ledwaba J, Steegen K, Rossouw I, <etal>et al<\/etal>.. (2012) Validation of a robust in-house genotyping assay for the detection of HIV-1 antiretroviral drug resistance. Pathpoint Conference, Cape Town, South Africa."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jviromet.2009.11.011","article-title":"Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1","volume":"163","author":"CL Wallis","year":"2010","journal-title":"J Virol Methods"},{"key":"ref15","first-page":"156","article-title":"2011 update of the drug resistance mutations in HIV-1","volume":"19","author":"VA Johnson","year":"2011","journal-title":"Top Antivir Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/bioinformatics\/bti607","article-title":"An automated genotyping system for analysis of HIV-1 and other microbial sequences","volume":"21","author":"T de Oliveira","year":"2005","journal-title":"Bioinformatics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/01.aids.0000216363.36786.2b","article-title":"HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes","volume":"20","author":"SY Rhee","year":"2006","journal-title":"AIDS"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1002\/j.1460-2075.1996.tb00777.x","article-title":"Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme","volume":"15","author":"NK Back","year":"1996","journal-title":"EMBO J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/00002030-200208160-00017","article-title":"M184V is associated with a low incidence of thymidine analogue mutations and low phenotypic resistance to zidovudine and stavudine","volume":"16","author":"M Ait-Khaled","year":"2002","journal-title":"AIDS"},{"key":"ref20","unstructured":"WHO (2009) Stavudine (d4T) phase-out management: Guiding principles."},{"key":"ref21","volume":"13","unstructured":"Venter WD, Innes S, Cotton M (2012) Low-dose stavudine trials: a public health priority for developing countries. Southern African Journal of HIV Medicine <volume>13<\/volume>.."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e67188","DOI":"10.1371\/journal.pone.0067188","article-title":"Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens","volume":"8","author":"GU Van Zyl","year":"2013","journal-title":"PLoS One"},{"key":"ref23","unstructured":"(2013) South African Antiretroviral Treatment Guidelines. In: NDoH, editor."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0097067","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T06:20:10Z","timestamp":1565418010000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0097067"}},"subtitle":[],"editor":[{"given":"Cheryl A.","family":"Stoddart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,5,9]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0097067","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,9]]}}}